Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL GASTROINTESTINAL CANCER DRUGS INDUSTRY
2.1 Summary about Gastrointestinal Cancer Drugs Industry
2.2 Gastrointestinal Cancer Drugs Market Trends
2.2.1 Gastrointestinal Cancer Drugs Production & Consumption Trends
2.2.2 Gastrointestinal Cancer Drugs Demand Structure Trends
2.3 Gastrointestinal Cancer Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Oncology
4.2.2 Radiology
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Specialized Cancer Treatment Centers
4.3.3 Clinics
4.3.4 Ambulatory Surgical Centers
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Oncology
5.2.2 Radiology
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Specialized Cancer Treatment Centers
5.3.3 Clinics
5.3.4 Ambulatory Surgical Centers
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Oncology
6.2.2 Radiology
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Specialized Cancer Treatment Centers
6.3.3 Clinics
6.3.4 Ambulatory Surgical Centers
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Oncology
7.2.2 Radiology
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Specialized Cancer Treatment Centers
7.3.3 Clinics
7.3.4 Ambulatory Surgical Centers
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Oncology
8.2.2 Radiology
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Specialized Cancer Treatment Centers
8.3.3 Clinics
8.3.4 Ambulatory Surgical Centers
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Oncology
9.2.2 Radiology
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Specialized Cancer Treatment Centers
9.3.3 Clinics
9.3.4 Ambulatory Surgical Centers
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Amgen Limited & Amgen Ireland Limited
10.1.2 Bristol-Myers Squibb Company
10.1.3 F. Hoffmann-La Roche Ltd.
10.1.4 Eli Lilly and Company
10.1.5 Johnson & Johnson Private Limited
10.1.6 GlaxoSmithKline plc.
10.1.7 Celgene Corporation
10.1.8 Pfizer Inc.
10.1.9 Sanofi
10.1.10 Novartis AG
10.2 Gastrointestinal Cancer Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Amgen Limited & Amgen Ireland Limited
10.2.2 Bristol-Myers Squibb Company
10.2.3 F. Hoffmann-La Roche Ltd.
10.2.4 Eli Lilly and Company
10.2.5 Johnson & Johnson Private Limited
10.2.6 GlaxoSmithKline plc.
10.2.7 Celgene Corporation
10.2.8 Pfizer Inc.
10.2.9 Sanofi
10.2.10 Novartis AG
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Gastrointestinal Cancer Drugs Product Type Overview
Table Gastrointestinal Cancer Drugs Product Type Market Share List
Table Gastrointestinal Cancer Drugs Product Type of Major Players
Table Brief Introduction of Amgen Limited & Amgen Ireland Limited
Table Brief Introduction of Bristol-Myers Squibb Company
Table Brief Introduction of F. Hoffmann-La Roche Ltd.
Table Brief Introduction of Eli Lilly and Company
Table Brief Introduction of Johnson & Johnson Private Limited
Table Brief Introduction of GlaxoSmithKline plc.
Table Brief Introduction of Celgene Corporation
Table Brief Introduction of Pfizer Inc.
Table Brief Introduction of Sanofi
Table Brief Introduction of Novartis AG
Table Products & Services of Amgen Limited & Amgen Ireland Limited
Table Products & Services of Bristol-Myers Squibb Company
Table Products & Services of F. Hoffmann-La Roche Ltd.
Table Products & Services of Eli Lilly and Company
Table Products & Services of Johnson & Johnson Private Limited
Table Products & Services of GlaxoSmithKline plc.
Table Products & Services of Celgene Corporation
Table Products & Services of Pfizer Inc.
Table Products & Services of Sanofi
Table Products & Services of Novartis AG
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Gastrointestinal Cancer Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Gastrointestinal Cancer Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Gastrointestinal Cancer Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Gastrointestinal Cancer Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f